Evaluation of alpha defensin, IL‐1 receptor antagonist, and IL‐18 levels in COVID‐19 patients with macrophage activation syndrome and acute respiratory distress syndrome-Reference-Cited by-同舟云学术

Evaluation of alpha defensin, IL‐1 receptor antagonist, and IL‐18 levels in COVID‐19 patients with macrophage activation syndrome and acute respiratory distress syndrome

Published:2020-10-30 Issue:4 Volume:93 Page:2090-2098
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Kerget Buğra¹^ORCID,Kerget Ferhan²^ORCID,Aksakal Alperen¹^ORCID,Aşkın Seda³^ORCID,Sağlam Leyla¹^ORCID,Akgün Metin¹^ORCID

Affiliation:

1. Department of Pulmonary Diseases Ataturk University School of Medicine Yakutiye Erzurum Turkey

2. Depertmant of Infection Diseases and Clinical Microbiology, Health Sciences University Erzurum Regional Education and Research Hospital Erzurum Turkey

3. Department of Biochemistry Ataturk University School of Medicine Erzurum Turkey

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26589

Reference20 articles.

1. Pharmacologic treatments for coronavirus disease 2019 (COVID‐19): a review;Sanders JM;JAMA,2020

2. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

3. COVID-19: consider cytokine storm syndromes and immunosuppression

4. COVID-19: immunopathology and its implications for therapy

5. IL-1, IL-18, and IL-33 families of cytokines

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity;Journal of Inflammation Research;2023-12

2. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients;PLOS ONE;2023-09-27

3. Biochemical Analysis of Ferritin and D-dimer in COVID-19 Survivors and Non-survivors;Cureus;2023-09-17

4. Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19;Frontiers in Immunology;2023-07-06

5. A New Approach To Predicting Prognosis In Sars-Cov-2 Infection: "MELD Scoring";Genel Tıp Dergisi;2023-06-30